Biohaven Therapeutics Ltd.
1 registered trial on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| Taldefgrobep Alfa in Adults With Overweight and Obesity NCT07281495 | Taldefgrobep alfa | Phase 2 | Active not recruiting | Biohaven Therapeutics Ltd. | 150 | Sep 2026 | Mar 20, 2026 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
